We are sharing a specialised part-time consulting opportunity for experienced payer and market access professionals with deep expertise in gross-to-net modelling, rebates, formulary strategy, pricing and reimbursement, and managed markets within the US pharmaceutical sector. This role supports an expert evaluation initiative focused on commercial medicines and drug-development programmes. Selected professionals will develop and critique evaluation rubrics, pressure-test gross-to-net and formulary assumptions, and assess whether coverage, rebate, and tiering strategies accurately reflect real-world payer behaviour across different drug classes. Key Responsibilities Market Access & Payer Strategy Evaluate market access strategies for commercial and development-stage pharmaceutical products Assess payer behaviour across different therapeutic areas and drug classes Review assumptions involving coverage, access restrictions, formulary placement, and reimbursement Apply practical US managed-markets expertise to commercial analyses Identify assumptions that are inconsistent with real-world payer decision-making Gross-to-Net & Rebate Analysis Develop and pressure-test gross-to-net assumptions Evaluate rebate expectations across different drug classes and payer segments Assess whether discounting and concession assumptions are commercially realistic Review the relationship between list price, rebates, access, and net revenue Identify unsupported or internally inconsistent gross-to-net assumptions Formulary Strategy Evaluate formulary-tier assumptions and expected product positioning Assess potential preferred, non-preferred, restricted, or excluded formulary status Review assumptions involving prior authorisation, step therapy, and other utilisation-management mechanisms Analyse how competitive dynamics may influence formulary access Assess whether proposed tiering strategies reflect realistic payer incentives Rubric Development & Expert Review Create structured evaluation rubrics for pharmaceutical market access analysis Critique existing rubrics for completeness, realism, and commercial relevance Define criteria reflecting experienced payer and market access judgment Identify missing considerations or weak assumptions in analytical frameworks Provide clear written reasoning supporting evaluation decisions Ideal Profile Strong candidates may have: At least 5 years of professional experience in market access, pricing and reimbursement, managed markets, or a closely related pharmaceutical function Hands-on experience with gross-to-net modelling and analysis Strong knowledge of pharmaceutical rebates and contracting dynamics Experience evaluating formulary placement and tiering by drug class Deep understanding of US payer behaviour and reimbursement structures Familiarity with biotech and pharmaceutical development programmes Strong commercial judgment and analytical reasoning Excellent written communication and attention to detail Current US-based professional experience Educational Background A background in business, economics, finance, healthcare, pharmacy, life sciences, or a related discipline may be highly relevant Advanced healthcare, commercial, or quantitative training may strengthen an application Equivalent professional experience in pharmaceutical market access or pricing and reimbursement may also be considered Practical payer and managed-markets expertise is particularly important for this engagement Nice to Have Experience working directly with health plans, PBMs, or payer organisations Background in pharmaceutical pricing strategy Experience with contracting and rebate negotiations Familiarity with Medicare, Medicaid, and commercial payer dynamics Experience evaluating launch access strategies Knowledge of utilisation management and formulary decision-making Experience advising biotechnology or pharmaceutical leadership teams Prior experience with structured expert review, rubric development, or AI evaluation Why This Opportunity Apply specialised market access expertise to sophisticated pharmaceutical evaluation work Analyse real-world gross-to-net, rebate, coverage, and formulary assumptions Help establish rigorous standards for evaluating pharmaceutical commercial strategies Work across multiple drugs, therapeutic areas, and payer scenarios Participate in a focused paid pilot with potential for recurring work Contribute specialist payer judgment to advanced AI evaluation Contract Details Independent contractor role Fully remote within the United States Part-time pilot engagement Approximately 10–20 total hours over an initial 1–2 week period Competitive rates between $170–$195 per hour depending on expertise and project scope At least 5 years of market access, pricing and reimbursement, or managed-markets experience is required Strong contributors may be considered for recurring or expanded engagements Work may include gross-to-net review, rebate analysis, formulary assessment, payer-strategy evaluation, rubric development, and expert critique Weekly payments via Stripe or Wise Projects may be extended, shortened, or adjusted depending on scope and performance Work will not involve access to confidential or proprietary information from any employer, client, or institution About the Platform This opportunity is available through 24-MAG LLC. We connect experienced professionals with remote consulting opportunities across technical, evaluation, and project-based workstreams. By submitting this application, you acknowledge that your information may be processed by 24-MAG LLC for recruitment and opportunity matching in accordance with our Privacy Policy: https://www.24-mag.com/privacy-policy .
Remote | US English Music & Audio Evaluation Specialist — $30–$55/hour
24 Mag
Remote | AI Safety & Adversarial Testing Specialist — $65–$80/hour
24 Mag
RN Supervisor UM Prior Auth
Affiliates Commonspirit
TikTok Shop Growth Lead/CSM
AMZ Advisers
AI Safety Specialist - Fully Remote | Upto $62/hr
Mercor
AI Safety Specialist - Fully Remote | Upto $22/hr
Mercor